A Geriatric Home Visit Program to Reduce Post-Hip Fracture Complications

NCT ID: NCT02058329

Last Updated: 2014-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2011-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall goal of the project is to reduce the incidence of post hip fracture morbidity and mortality by conducting geriatric fellow periodic home visits.The assessment will be multidisciplinary and will include assessments of functional status, depression, environmental risks and medical conditions. This group will be compared against a group followed by the usual standard of care post hip fracture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients post hip fracture on the hospital's rehabilitation service that will be discharged to home will be enrolled after obtaining consent. Patients will be randomized into the intervention group and the usual standard of care group.We will be recruiting a total of 100 patients , with equal numbers for each group.All patients will undergo an initial assessment by a Geriatric fellow prior to discharge . The intervention group will be seen at the time of discharge in the hospital and at home at 1, 3, and 6 months post hip fracture. The control group will be seen at the time of discharge in the hospital and then again at 6 months for follow up. The two groups will then be compared for multiple known complications post hip fractures well as mortality.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fracture Infection Depression Gait Instability Debility

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No intervention

Standard of care with no home visit

Group Type NO_INTERVENTION

No interventions assigned to this group

Home Visit

After the post hip-fracture patient is discharged to home, there will be home visits by a geriatric fellow assess overall function and response to treatment/s by depression screen, FIM scores, and environmental risk assessment

Group Type EXPERIMENTAL

Home Visit

Intervention Type OTHER

A geriatric fellow will conduct a comprehensive in hospital post discharge assessment of hip fracture patients discharged to home in the intervention group.Follow up home visits will occur at 1,3 and 6 months post discharge.Any problems will be referred to the patient's primary care physician.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home Visit

A geriatric fellow will conduct a comprehensive in hospital post discharge assessment of hip fracture patients discharged to home in the intervention group.Follow up home visits will occur at 1,3 and 6 months post discharge.Any problems will be referred to the patient's primary care physician.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All post hip fracture patients on the hospital's rehabilitation service being discharged to home .

Exclusion Criteria

* Patients discharged to nursing homes or rehabilitation facilities.
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Staten Island University Hospital

OTHER

Sponsor Role collaborator

Northwell Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Garbis Dabaghian

M.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark Jarrett, M.D.

Role: PRINCIPAL_INVESTIGATOR

Staten Island University Hospital

Marianne Smith, M.D.

Role: STUDY_DIRECTOR

Staten Island University Hospital

Garbis Dabagian, M.D.

Role: PRINCIPAL_INVESTIGATOR

Staten Island University Hospital

Donna Seminara, M.D.

Role: PRINCIPAL_INVESTIGATOR

Staten Island University Hospital

Jeffery Weinberg, M.D.

Role: PRINCIPAL_INVESTIGATOR

Staten Island University Hospital

Mario Castellanos, M.D.

Role: PRINCIPAL_INVESTIGATOR

Staten Island University Hospital

Anita Szerszen, M.D.

Role: PRINCIPAL_INVESTIGATOR

Staten Island University Hospitial

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Staten Island University Hospital

Staten Island, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

McGinn T, Conte JG, Jarrett MP, ElSayegh D. Decreasing mortality for patients undergoing hip fracture repair surgery. Jt Comm J Qual Patient Saf. 2005 Jun;31(6):304-7. doi: 10.1016/s1553-7250(05)31038-5.

Reference Type BACKGROUND
PMID: 15999957 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

08-023

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.